Using CancerGRACE.org

Search By

Create a Profile

Create a profile on GRACE.  Your dashboard lets you save information that is important to you, and allows you to join the conversation!  Click the 'My Account' link to return to your dashboard at any time.  

 

Featured Content

Image
Watch the Webinar Now ON Demand
Video

The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended. ¡Los vídeos están disponibles BAJO DEMANDA! Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas. Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y...

Video

In these videos, Dr. Jared Weiss provides a brief overview of the HPV vaccination and its role in head and neck cancer, examines cetuximab as the prior standard of care for patients with head and neck cancer, discusses the current standard of care for these patients, and discusses the prognosis of patients with advanced HPV+ head and neck cancer. To watch the complete playlist, click here . Special thanks to Merck for its sponsorship of this program.

Image
PEA Program 2024-25
Video

In this Program, Drs. Arya Mariam Roy, Assistant Professor at The Ohio State University, Erick Saldanha, Medical Oncologist & Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, Guilherme Sacchi de Camargo Correia, Hematology and Oncology fellow at Mayo Clinic in Jacksonville, Florida, Maria Velez Velez, Hematology-Oncology fellow at the University of California, Los Angeles, and Marie Dreyer, second-year hematology/oncology fellow at the Robert H. Lurie Comprehensive Cancer Center...

Image
GU cancers 2025
Video

In this series, Dr. Matthew Kurian, Staff Oncologist at St. Elizabeth Healthcare, and Dr. Karine Tawagi, Division of Hematology & Oncology at UI Health, discuss topics related to GU cancers, including kidney and bladder cancers. To watch the complete playlist, click here .

Image
videoteca de cáncer de pulmón
Video

Como parte de la Videoteca de Cáncer de Pulmón en Español 2023, el Dr. Alejandro R. Calvo, MD, FACP, aborda temas relacionados con el cáncer de pulmón, desde el diagnóstico hasta las opciones de tratamiento, y preguntas y conceptos erróneos comunes. Para ver la serie completa de click aquí.

Image
Cased Based Panel Discussions - Lung Cancer
Video

In these videos, the panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and looks at data from the Laura Trial. They also discuss treatment options for a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions. To watch the complete playlist, click here .

Image
2023 Leading Developments and current questions in lung cancer
Video

For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and Founder and President of GRACE, Christine Lovly, Associate Professor of Medicine, Division of Hematology-Oncology, and Dr. Alfredo Addeo, Medical Oncologist, Department of Oncology at the University Hospital of Geneva (HUG), discuss the most current and emerging treatment information recently presented at ASCO. To watch the complete playlist, click here .

Term Dictionary

Read what our community is saying about GRACE

Thank you SO much for this site! I found great info on this site when I was originally diagnosed with NSCLC in 2014. After my lobectomy in Feb. 2015, staged 1B, I assumed I would be cancer-free forever. Unfortunately, this week a CT revealed that the cancer has returned in both lungs and I am eager to gather as much information as I can to give myself the best outcome possible. Thank you so much for the reply and words of encouragement, Janine! In addition to the moral support, this site has already provided me with invaluable answers to some questions I've had regarding first line treatments (e.g., Afatinib v. Tarceva, Immunotherapy v. oral targeted therapy for EGFR mutations). Thank you again!

Tripletmom